Portela & CA., S.A.
Records under this name other than the patents Portela & CA., S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,999,100 | Method for chiral inversion of (S)-(+)-and (R)-(−)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,834,177 | Method for preparation of 10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,288,532 | Asymmetric catalytic reduction of oxcarbazepine Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,550,759 | Nitrocatechol derivatives as COMT inhibitors Formerly held Term ended Ended no later than Jul 26, 2026 · USPTO record | Term ended | Ended no later than Jul 26, 2026 | USPTO record |
| US 7,667,075 | Sulphonylated Diphenylethylenediamines, Method for Their Preparation and Use in Transfer Hydrogenation Catalysis Formerly held Term ended Term ended Nov 1, 2025 · High confidence | Term ended | Term ended Nov 1, 2025 | High confidence |
| US 7,189,846 | Method for racemization of (S)-(+)- and (R)-(−)-10,11-dihydro-10-hydroxy-5h-dibenz[B,F]azepine-5-carboxamide and optically enriched mixtures thereof Formerly held Term ended Term ended Jun 30, 2025 · USPTO record | Term ended | Term ended Jun 30, 2025 | USPTO record |
| US 10,675,287 | Methods of treatment of partial onset seizures using eslicarbazepine acetate Formerly held Term ended Ended no later than May 6, 2025 · USPTO record | Term ended | Ended no later than May 6, 2025 | USPTO record |
| US 10,695,354 | Methods of treatment of partial onset seizures using eslicarbazepine acetate Term ended Ended no later than May 6, 2025 · USPTO record | Term ended | Ended no later than May 6, 2025 | USPTO record |
| US 10,702,536 | Methods of treatment of partial onset seizures using eslicarbazepine acetate Term ended Ended no later than May 6, 2025 · USPTO record | Term ended | Ended no later than May 6, 2025 | USPTO record |
| US 7,820,813 | Method for preparation of (S)-(+)- and (R)-(−)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide Term ended Term ended Jan 10, 2025 · USPTO record | Term ended | Term ended Jan 10, 2025 | USPTO record |